Market Place
Sourcing Support
US FDA approves expanded use of Lilly`s bowel disease drug
16 Jan 2025 //
PRESS RELEASE
Eli lilly`s Biologic Omvoh Receives Suppl Approval in US
15 Jan 2025 //
FDA
Eli Lilly misses 2024 revenue expectations, stock dips 7%
15 Jan 2025 //
ENDPTS
Eli Lilly to buy Scorpion cancer therapy for up to $2.5 billion
14 Jan 2025 //
REUTERS
In a unique collab, Lilly and a16z forge new $500M venture fund
11 Jan 2025 //
FIERCE BIOTECH
Mediar, Lilly License Antibody for Idiopathic Pulmonary Fibrosis
10 Jan 2025 //
PR NEWSWIRE
Lilly crafts deal with UK biotech for new ALS antibodies
10 Jan 2025 //
PRNEWS WIRE
Lilly to establish new global capability centre in Hyderabad
09 Jan 2025 //
EXPRESSPHARMA
Lilly to participate in J.P. Morgan Healthcare Conference
07 Jan 2025 //
PR NEWSWIRE
Roche projected to claim pharma`s 2025 sales crown
03 Jan 2025 //
FIERCE PHARMA
Lilly seeks to intervene in compounded tirzepatide lawsuit
02 Jan 2025 //
FIERCE PHARMA
Lilly Joins Lawsuit Over Compounded Weight-Loss Drugs
02 Jan 2025 //
REUTERS
Novo, Lilly poised to overcome GLP-1 supply constraints in 2025
02 Jan 2025 //
FIERCE PHARMA
Teva looks to peel back the onion on mental health
02 Jan 2025 //
FIERCE PHARMA
Lilly’s Zepbound set to ‘dominate’ obesity market
02 Jan 2025 //
FIERCE PHARMA
Lupin acquires Huminsulin from Lilly, enhance diabetes portfolio
31 Dec 2024 //
INDPHARMAPOST
Lilly drug Mounjaro offered in Britain`s NHS after watchdog nod
26 Dec 2024 //
REUTERS
FDA Approves First Medication for Obstructive Sleep Apnea
23 Dec 2024 //
FDA
Weight-Loss Drug Developers Eye $150 Billion Market
20 Dec 2024 //
REUTERS
Novo and Lilly Face Growing Competition from Weight Loss Copies
20 Dec 2024 //
REUTERS
FDA Confirms Lilly’s GLP-1s Are Not in Shortage
20 Dec 2024 //
BIOSPACE
Obesity giants will begin $80 bln M&A face-off
19 Dec 2024 //
REUTERS
Eli Lilly`s Alzheimer`s treatment approved in China
18 Dec 2024 //
REUTERS
Nestle launches protein shots for US weight-loss drug
18 Dec 2024 //
REUTERS
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Lilly and EVA Pharma Announce Insulin Approval and Release in Egypt
17 Dec 2024 //
PR NEWSWIRE
Cheplapharm acquires Gemzar from Lilly
16 Dec 2024 //
PHARMAWEB
Innovent & Lilly Expand Collaboration for Jaypirca
16 Dec 2024 //
PR NEWSWIRE
Innovent & Lilly Expand Collab for Jaypirca® Commercialization
15 Dec 2024 //
PR NEWSWIRE
Lilly`s Omvoh® Gets CHMP Nod For Active Crohn`s Disease
13 Dec 2024 //
PR NEWSWIRE
Lilly`s Mounjaro Beats Wegovy In UK Obesity Drug Market
12 Dec 2024 //
REUTERS
The brain is Eli Lilly`s next target for its obesity meds
12 Dec 2024 //
ENDPTS
Lilly Offers Single-Dose Weight-Loss Drug Via Ro Telehealth
11 Dec 2024 //
REUTERS
Boehringer, Lilly bring kidney disease test push to Rose Parade
11 Dec 2024 //
FIERCE PHARMA
How will Trump approach healthcare? Lilly CEO gives some hints
11 Dec 2024 //
FIERCE PHARMA
Lilly`s oral SERD Ember counts on Verzenio to broaden its glow
11 Dec 2024 //
FIERCE BIOTECH
High-flying Eli Lilly plots $15B share buyback plan
11 Dec 2024 //
FIERCE PHARMA
Lilly CEO says tax & Regulation reform, drug affordability focuses
11 Dec 2024 //
REUTERS
High-flying Eli Lilly plots $15B share buyback campaign
10 Dec 2024 //
FIERCE PHARMA
CORE Kidney, Boehringer, Lilly Focus on Kidney Health at Parade
09 Dec 2024 //
PR NEWSWIRE
Lilly Announces $15B Share Repurchase and Dividend Increase
09 Dec 2024 //
PR NEWSWIRE
Phase 3 Results for Lilly`s Jaypirca® in CLL at ASH 2024
09 Dec 2024 //
PR NEWSWIRE
Eli Lilly To Launch Weight Loss Drug In India Next Year
09 Dec 2024 //
ECONOMICTIMES
ASH: Lilly defends survival data blemish in novel BTK trial win
09 Dec 2024 //
FIERCE PHARMA
Lilly Invests $3B To Boost Wisconsin Plant For Obesity Drugs
07 Dec 2024 //
REUTERS
Trump hosted dinner with CEOs from Pfizer, Lilly & PhRMA: Axios
06 Dec 2024 //
FIERCE PHARMA
Cambrex Partners with Lilly to Support Biotech Manufacturing
05 Dec 2024 //
PR NEWSWIRE
Lilly`s Zepbound Beats Wegovy In Weight Loss Trial: 20.2% Vs. 13.7%
05 Dec 2024 //
PR NEWSWIRE
England`s NICE to phase rollout for Lilly`s tirzepatide in obesity
05 Dec 2024 //
FIERCE PHARMA
Rondo & Lilly To Develop CD28 Bispecifics For Solid Tumors
04 Dec 2024 //
BUSINESSWIRE
Legal Challenge Over Lilly’s GLP-1 Shortages
26 Nov 2024 //
BIOSPACE
Laekna with Lilly to develop muscle preserving obesity drug
21 Nov 2024 //
PRESS RELEASE
Verge Genomics Announces Milestones In ALS Collaboration With Lilly
20 Nov 2024 //
GLOBENEWSWIRE
ACCC & Lilly Offer Grants to Patient Loss in Precision Oncology
20 Nov 2024 //
PR NEWSWIRE
Lilly announces changes on board of directors
19 Nov 2024 //
PR NEWSWIRE
Lilly pill cuts genetic form of cholesterol nearly 86% in study
19 Nov 2024 //
REUTERS
Lilly’s Tirzepatide Reduces Heart Failure Risk in HFpEF & Obesity
16 Nov 2024 //
PR NEWSWIRE
Lilly sues US agency over blocking of drug-rebate program
15 Nov 2024 //
REUTERS
Eli Lilly sues US government over proposed 340B rebate model
15 Nov 2024 //
ENDPTS
Eli Lilly`s weight-loss drug helps nearly 99% of patients remain diabetes-free
14 Nov 2024 //
REUTERS
